Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives

V. Sidova, P. Zoufaly, J. Pokorny, P. Dzubak, M. Hajduch, I. Popa, M. Urban,

. 2017 ; 12 (2) : e0171621. [pub] 20170203

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031070

In this work, we describe synthesis of conjugates of betulinic acid with substituted triazoles prepared via Huisgen 1,3-cycloaddition. All compounds contain free 28-COOH group. Allylic bromination of protected betulinic acid by NBS gave corresponding 30-bromoderivatives, their substitution with sodium azides produced 30-azidoderivatives and these azides were subjected to CuI catalysed Huisgen 1,3-cycloaddition to give the final conjugates. Reactions had moderate to high yields. All new compounds were tested for their in vitro cytotoxic activities on eight cancer and two non-cancer cell lines. The most active compounds were conjugates of 3β-O-acetylbetulinic acid and among them, conjugate with triazole substituted by benzaldehyde 9b was the best with IC50 of 3.3 μM and therapeutic index of 9.1. Five compounds in this study had IC50 below 10 μM and inhibited DNA and RNA synthesis and caused block in G0/G1 cell cycle phase which is highly similar to actinomycin D. It is unusual that here prepared 3β-O-acetates were more active than compounds with the free 3-OH group and this suggests that this set may have common mechanism of action that is different from the mechanism of action of previously known 3β-O-acetoxybetulinic acid derivatives. Benzaldehyde type conjugate 9b is the best candidate for further drug development.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031070
003      
CZ-PrNML
005      
20200728083752.0
007      
ta
008      
171025s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0171621 $2 doi
035    __
$a (PubMed)28158265
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sidova, Veronika $u Department of Organic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic.
245    10
$a Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives / $c V. Sidova, P. Zoufaly, J. Pokorny, P. Dzubak, M. Hajduch, I. Popa, M. Urban,
520    9_
$a In this work, we describe synthesis of conjugates of betulinic acid with substituted triazoles prepared via Huisgen 1,3-cycloaddition. All compounds contain free 28-COOH group. Allylic bromination of protected betulinic acid by NBS gave corresponding 30-bromoderivatives, their substitution with sodium azides produced 30-azidoderivatives and these azides were subjected to CuI catalysed Huisgen 1,3-cycloaddition to give the final conjugates. Reactions had moderate to high yields. All new compounds were tested for their in vitro cytotoxic activities on eight cancer and two non-cancer cell lines. The most active compounds were conjugates of 3β-O-acetylbetulinic acid and among them, conjugate with triazole substituted by benzaldehyde 9b was the best with IC50 of 3.3 μM and therapeutic index of 9.1. Five compounds in this study had IC50 below 10 μM and inhibited DNA and RNA synthesis and caused block in G0/G1 cell cycle phase which is highly similar to actinomycin D. It is unusual that here prepared 3β-O-acetates were more active than compounds with the free 3-OH group and this suggests that this set may have common mechanism of action that is different from the mechanism of action of previously known 3β-O-acetoxybetulinic acid derivatives. Benzaldehyde type conjugate 9b is the best candidate for further drug development.
650    _2
$a protinádorové látky $x chemie $x farmakologie $7 D000970
650    _2
$a benzaldehydy $x chemie $7 D001547
650    _2
$a buněčný cyklus $x účinky léků $7 D002453
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a cykloadiční reakce $7 D061565
650    _2
$a lidé $7 D006801
650    _2
$a triazoly $x chemie $7 D014230
650    _2
$a triterpeny $x chemie $7 D014315
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zoufaly, Pavel $u Department of Organic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Pokorny, Jan $u Department of Organic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Dzubak, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Popa, Igor $u Department of Organic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Urban, Milan $u Department of Organic Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $7 xx0117688
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 12, č. 2 (2017), s. e0171621
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28158265 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20200728083748 $b ABA008
999    __
$a ok $b bmc $g 1254663 $s 992097
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c 2 $d e0171621 $e 20170203 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace